| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.
|
Circulation
|
2009
|
8.11
|
|
2
|
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
|
N Engl J Med
|
2005
|
4.16
|
|
3
|
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.
|
Mayo Clin Proc
|
2007
|
3.12
|
|
4
|
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.
|
Circulation
|
2002
|
2.93
|
|
5
|
Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices.
|
Clin Chem
|
2013
|
2.90
|
|
6
|
Endurance exercise as a countermeasure for aging.
|
Diabetes
|
2008
|
2.83
|
|
7
|
Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
|
Eur Heart J
|
2004
|
2.29
|
|
8
|
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
|
Blood
|
2004
|
2.01
|
|
9
|
Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans.
|
Arterioscler Thromb Vasc Biol
|
2005
|
2.00
|
|
10
|
Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
|
Circulation
|
2007
|
1.89
|
|
11
|
Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome.
|
Eur Heart J
|
2009
|
1.77
|
|
12
|
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins.
|
Lancet
|
2003
|
1.64
|
|
13
|
Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
|
Blood
|
2005
|
1.64
|
|
14
|
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
|
J Lipid Res
|
2006
|
1.61
|
|
15
|
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.
|
Clin Chem
|
2009
|
1.57
|
|
16
|
Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.56
|
|
17
|
Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
|
Stroke
|
2008
|
1.52
|
|
18
|
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
|
Am J Cardiol
|
2008
|
1.51
|
|
19
|
Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.43
|
|
20
|
Oxidative stress in obstructive sleep apnoea.
|
Eur Heart J
|
2005
|
1.22
|
|
21
|
C-reactive protein levels are influenced by common IL-1 gene variations.
|
Cytokine
|
2002
|
1.17
|
|
22
|
Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.
|
Eur Heart J
|
2006
|
1.11
|
|
23
|
Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults.
|
Prev Cardiol
|
2006
|
1.05
|
|
24
|
Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships.
|
Am J Hypertens
|
2005
|
1.02
|
|
25
|
Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation.
|
Circ Res
|
2005
|
1.02
|
|
26
|
Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.
|
Prostaglandins Leukot Essent Fatty Acids
|
2013
|
1.01
|
|
27
|
Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: implications for clinical utility.
|
J Clin Lipidol
|
2013
|
0.95
|
|
28
|
Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle-brachial index.
|
Vasc Med
|
2004
|
0.94
|
|
29
|
Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?
|
Am J Cardiol
|
2008
|
0.93
|
|
30
|
Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy.
|
Atherosclerosis
|
2009
|
0.92
|
|
31
|
Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.
|
Mayo Clin Proc
|
2002
|
0.92
|
|
32
|
Sex-specific changes in platelet aggregation and secretion with sexual maturity in pigs.
|
J Appl Physiol (1985)
|
2004
|
0.91
|
|
33
|
Myocardial tissue remodeling in adolescent obesity.
|
J Am Heart Assoc
|
2013
|
0.90
|
|
34
|
Effect of myocardial ischemia on cardiac troponin I and T.
|
Am J Cardiol
|
2002
|
0.90
|
|
35
|
C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal echocardiographic study.
|
Arch Intern Med
|
2004
|
0.89
|
|
36
|
Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women.
|
J Clin Endocrinol Metab
|
2007
|
0.87
|
|
37
|
Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus risk.
|
Curr Vasc Pharmacol
|
2007
|
0.87
|
|
38
|
Concerns regarding lipoprotein particle measurement by ion mobility analysis.
|
Clin Chem
|
2008
|
0.86
|
|
39
|
Nutritional assessment of serum and hepatic vitamin A levels in patients with cirrhosis.
|
JPEN J Parenter Enteral Nutr
|
2002
|
0.86
|
|
40
|
Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
|
J Heart Lung Transplant
|
2007
|
0.85
|
|
41
|
Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease.
|
Mayo Clin Proc
|
2007
|
0.85
|
|
42
|
Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid.
|
Atherosclerosis
|
2002
|
0.82
|
|
43
|
Low-density lipoprotein particle size and coronary atherosclerosis in subjects belonging to hypertensive sibships.
|
Am J Hypertens
|
2004
|
0.82
|
|
44
|
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction.
|
Stroke
|
2004
|
0.82
|
|
45
|
Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetry.
|
Clin Chim Acta
|
2008
|
0.82
|
|
46
|
Role of lipoprotein-associated phospholipase A2 in atherosclerosis.
|
Curr Atheroscler Rep
|
2008
|
0.81
|
|
47
|
Association between the paraoxonase-1 192Q>R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease.
|
Mayo Clin Proc
|
2008
|
0.81
|
|
48
|
Assessment of clinical performance without adequate analytical validation: A prescription for confusion.
|
Clin Biochem
|
2011
|
0.81
|
|
49
|
Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction.
|
Mol Diagn Ther
|
2007
|
0.80
|
|
50
|
Detectable troponin levels predict poor prognosis in patients with left ventricular dysfunction undergoing internal defibrillator implantation.
|
Pacing Clin Electrophysiol
|
2007
|
0.80
|
|
51
|
Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes.
|
Endocr Pract
|
2007
|
0.80
|
|
52
|
Relation of C-reactive protein and fibrinogen to coronary artery calcium in subjects with systemic hypertension.
|
Am J Cardiol
|
2003
|
0.80
|
|
53
|
Variability of lipoprotein-associated phospholipase A2 measurements.
|
Clin Chem
|
2008
|
0.79
|
|
54
|
Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method.
|
Clin Biochem
|
2004
|
0.79
|
|
55
|
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms.
|
Clin Chem
|
2008
|
0.78
|
|
56
|
Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
|
Transplantation
|
2008
|
0.78
|
|
57
|
Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community.
|
Atherosclerosis
|
2008
|
0.77
|
|
58
|
Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men.
|
J Clin Endocrinol Metab
|
2010
|
0.77
|
|
59
|
Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women.
|
J Clin Endocrinol Metab
|
2008
|
0.77
|
|
60
|
Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients.
|
Stroke
|
2002
|
0.77
|
|
61
|
Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practice.
|
J Cardiovasc Transl Res
|
2014
|
0.77
|
|
62
|
A patient with primary biliary cirrhosis and elevated LDL cholesterol.
|
Clin Chem
|
2009
|
0.76
|
|
63
|
In reply.
|
Clin Chem
|
2013
|
0.75
|
|
64
|
Does APOE genotype modify the relations between serum lipid and erythrocyte omega-3 fatty acid levels?
|
J Cardiovasc Transl Res
|
2014
|
0.75
|
|
65
|
The current and future landscape of urinary thromboxane testing to evaluate atherothrombotic risk.
|
Rev Cardiovasc Med
|
2014
|
0.75
|
|
66
|
Serum and hepatic vitamin E assessment in cirrhotics before transplantation.
|
JPEN J Parenter Enteral Nutr
|
2003
|
0.75
|
|
67
|
Plasma thrombosis markers following cerebral infarction in African Americans.
|
Thromb Res
|
2005
|
0.75
|